Pfizer pledges $100M for antimicrobial resistance

By The Science Advisory Board staff writers

July 9, 2020 -- Pfizer has pledged $100 million to the Antimicrobial Resistance (AMR) Action Fund to address the need for new antibiotics due to the rapid rise of antibiotic-resistant infections.

The AMR Action Fund is a collaboration among over 40 biopharmaceutical companies with the goal of bringing two to four new antibiotics to the clinic by 2030 through partnerships with pharmaceutical companies, philanthropies, development banks, and multilateral organizations.

The new commitment builds on Pfizer's existing work to address AMR through the development of vaccines that reduce the need for antibiotics, active research in anti-infectives, and work with clinical partners to close gaps in infectious disease treatments. The company also manages Atlas, a public access platform for antifungal and antibacterial resistance data.

Machine learning helps identify antimicrobial-resistant bacteria
A new graphical user interface-driven, machine learning-based approach has successfully identified antimicrobial resistance genes for gram-positive and...
Artificial intelligence helps researchers find new antibiotics
To address antibiotic resistance, researchers have developed a machine-learning approach that can search millions of known chemicals to find new...
Bacterial evolution reveals method to fight antibacterial resistance
Different types of bacteria have evolved to develop unique mechanisms for achieving the same antibacterial function -- a finding that could lead to new...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter